Virtual Event, Worldwide : 5 - 6 December 2023
Welcome to the EACR-AstraZeneca Virtual Conference 'Cancer Epigenetics' 2023! This page brings together all the information you’ll need while attending this EACR Virtual Conference.
We run our EACR Virtual Conferences across two Zoom formats – Webinars (for the conference talks) and Meetings (for our poster discussion sessions). As an attendee during the webinar, you won’t be able to switch on your camera and will need to have your microphone enabled to ask questions. During the Poster Discussion Sessions, you will be in control of your own camera and microphone. You will need to have both switched on to get the most out of these sessions.
Approximately 24 hours before the start of each day of the conference, you should receive an email from Zoom with your link to access the conference webinar. As this is an automated email, it might be sorted into your junk folder. If you have not received your email by the morning of the conference, then please email Hannah.Barrs@eacr.org. This webinar link is specific to you and should not be shared with anyone else.
If you click on this link before the conference is due to start, you will see a holding screen. Once EACR has started the webinar, the system will automatically move you into the conference space. If you need to leave the conference, you can rejoin later using the same link.
There are two ways that you can ask questions to our speakers during the conference talks.
If you want to ask your question live, then please use the ‘Raise Hand’ button. This might be located at the top or bottom of your screen. The Chair will invite you to ask your question, and the EACR will enable your microphone.
If you do not want to ask your question live, then use the Q&A box. This might be found at the bottom of your screen. You will have the option to ask your question anonymously if that is your preference. The Chair will then read questions from the Q&A box on your behalf.
Tuesday 05 December, 17:05-18:05 CET
Wednesday 06 December, 12:30-13:30 CET
The Poster Discussion Sessions are scheduled to take place at the end of Day 1 and the beginning of Day 2 of the conference. They will each be held as a seperate Zoom meeting. You will receive the links to join these meetings in the email sent to you a week before the conference. During the Virtual Poster Discussion Sessions, each poster presenter will have their very own 'Breakout Room' where they will be displaying their poster. All attendees will have full control over their camera and microphone, be able to communicate using the chat, and navigate across the breakout rooms to view each poster and talk to the poster presenter.
When you first enter the meeting, you will go straight to the “Lobby”. EACR staff will be there throughout the session should you have any questions. Details of each of the posters on display in the session and their relevant breakout rooms will also be shown on the screen in this main area. You can also access the list of posters via our Online Abstract Book and through our ‘On the Day’ guide (you can find the lists further down this page!).
Conference participants are invited to join any of the rooms to browse the posters, discuss the work on show and make new connections. To navigate to a specific breakout room, click on the ‘Breakout Room’ button and then on the specific room you would like to join. Zoom will then move you to that breakout room. Keep in mind that each poster discussion session only lasts 1 hour, so make sure you leave yourself plenty of time to browse!
If you are a Poster Presenter, you will have your own designated breakout room which corresponds to your poster number. This space is entirely yours and can be used to present your research however you think is best! We recommend sharing your poster as a PowerPoint slide or presentation.
Feedback from our previous Virtual Poster Discussion Sessions:
"The poster sessions were extremely well-organised and interactive. This type of session provides a very inspiring platform to interact with other people working in the field more openly and facilitates great scientific exchange."
"I felt fully involved in the conference most especially during the breakout session where I was able to present my work and also get to discuss it with other great minds."
"The virtual social and networking experiences provided me with valuable connections and insights that I wouldn’t have been able to gain otherwise."
Posters on display:
Poster 01 - Daniel Angelov, ‘Genome-wide CRISPR-Cas9 Screens Predict Resistance Mechanisms to EZH2 inhibitors (EZH2i) in B-cell Non-Hodgkin Lymphoma (NHL)’
Poster 02 – Buse Cevatemre, ‘Uncovering Potential Targets in Taxane Resistant Prostate Cancer’
Poster 03 – María Rodrigo-Faus, ‘PRMT7: an arginine methyl-transferase that enhances the progression of localized prostate cancer to metastasis’
Poster 04 – Batoul Abizamer, ‘Unlocking the Potential of DNA Methylation in Targeting Oncogenic RPS2: A Promising Avenue for Hepatocellular Carcinoma Therapy and Biomarker Discovery’
Poster 05 – Faisal Alhedyan, ‘Exploring Oral Cancer Progression: Gaining Insight into Transcriptomic and Epigenomic Profiles through Tissue-Engineered Models’
Poster 06 – Benoît Aliaga, ‘Insights into gene age and gene expression organisation in 3D chromatin structure’
Poster 07 – Sara Badodi, ‘Targeting epigenetic dysregulation in medulloblastoma with poor prognosis’
Poster 08 – Murali Bashyam, ‘YIN-YANG of chromatin remodelers: novel oncogenic cytoplasmic roles for ARID domain containing BAF components’
Poster 09 – Tabea Bauer, ‘Functional analysis of FLYWCH1 as an epigenetic factor involved in development of platinum-resistance in epithelial ovarian cancer’
Poster 10 – Dino Bekric, ‘Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract Cancer’
Poster 11 – Elisa Boldrin, ‘Global hypomethylation in esophageal adenocarcinoma and Barrett’s esophagus: a MSRE-ddPCR assay in liquid biopsy’
Poster 12 – Vasyl Chekhun, ‘Comparison of miRNA expression pattern in young and old breast cancer patients’
Poster 13 – Ipek Bulut, ‘The role of Menin and LEDGF complexes for the acquisition and reversion of Taxane Resistance in Castration Refractory Prostate Cancers (CRPC)’
Poster 14 – Catalina Capó Serra, ‘ASPA as a new regulator of Cancer-Associated Fibroblasts phenotype and its implication in cancer’
Poster 15 – Davide Chiesi, ‘Exploring BET inhibitor-mediated modulation of cancer relevant gene signatures in glioblastoma’
Poster 16 – Margit Cichna-Markl, ‘MGMT enhancer methylation as potential biomarker in glioblastoma’
Poster 17 – Marco Fantuz, ‘Single nuclei multi-omic approach reveals permanent reprogramming of exocrine cells after pancreatitis’
Poster 18 - Mónica Teotónio Fernandes, ‘CITED4 methylation is a novel prognosis biomarker in gliomas’
Poster 19 – Thaarun Haldorai Sounder, ‘Identification Of Novel Genes That Are Dysregulated Due To Altered DNA Methylation In Metastatic Breast Cancer’
Poster 20 - Zoe Hawking, ‘Exploring 5'-Azacitidine monotherapy for the treatment of TET2 mutated cancers: a pan-cancer approach’
Poster 21 – Shakhzada Ibragimova, ‘Defining the molecular role of transcription factor FOXC1 in triple-negative breast cancer’
Poster 22 – Arda ışıklar, ‘Beyond Traditional Treatments: HDAC6 Inhibition and the Promise of Compound 9b in CRPCa’
Poster 23 – Yagmur Kala, ‘Epigenetic Knock Out Library (EPIKOL) Screens Identify Novel Chromatin Regulators in Temozolomide Resistant Glioblastoma Models’
Poster 24 – Miriam Kokal, ‘Functional analysis of Baz2a containing chromatin remodeling complexes in metastasis models’
This session will end at 18:05 CET so please make sure you give yourself enough time to browse each of the posters on display!
Before the main programme of scientific talks on Day 2 we will hold our second 60-minute ‘Virtual Poster Discussion Session’, showcasing even more posters submitted for the conference. Please make sure you have received the link to this meeting and that you have joined the session by 12:30 CET.
Posters on display:
Poster 25 – Claudia Leotta, ‘Dual-function agents targeting epigenetic modifications as uveal melanoma drugs’
Poster 26 - Flávia Martins, ‘The Epigenetics of Tolerance to KRAS Inhibition in Colorectal Cancer: Insights into Chromatin Adaptations and Transcriptional Dynamics’
Poster 27 – Ana Neves Costa, ‘DNA damage independent inhibition of NF-kB transcription by anthracyclines’
Poster 28 – Michela Notorangelo, ‘Dynamic tracking of DNA hypermethylation patterns for enhanced therapy monitoring’
Poster 29 – Petar Ozretić, ‘The role of miR-16-5p and miR-107 in BRCA1 and BRCA2 expression regulation in high-grade serous ovarian carcinoma’
Poster 30 – Ulrich Pfeffer, ‘The demethylating agent guadecitabine reduces myeloid derived suppressor cells and induces expression of genes encoding components of the antigen presenting machinery via induction of the transcription factor NLRC5’
Poster 31 – Evangelos Prokakis, ‘USP22 supports the aggressive behavior of basal-like breast cancer by stimulating cellular respiration’
Poster 32 – Walter Pulverer, ‘DNA methylation biomarkers for minimally invasive and early detection of colorectal cancer using liquid biopsies’
Poster 33 – Vanessa Ribeiro, ‘The impact of Laminin-a2 deficiency in melanoma’
Poster 34 – Sedef Sarac, ‘Interrogation of the function of KDM6A and KDM6B histone demethylases in isocitrate dehydrogenase (IDH) mutant glioma’
Poster 35 – Baris Sergi, ‘Implications of Lysosomal Sequestration and Exocytosis in Chemotherapeutic Resistance: The Role of Epigenetic Modifiers’
Poster 36 – Mukund Sharma, ‘Convergence of RAS and PP2A activity on epigenetic gene regulation’
Poster 37 – Ibha Singh, ‘Epigenetic targeting of oncogene amplified cisplatin-resistant ovarian cancer’
Poster 38 – Siarhei Smirnou, ‘MGMT promoter methylation status and mRNA expression level in different cancer types’
Poster 39 – Sweta Srivastava, ‘RhoC, Tet2, and WDR5 targeting in cancer stem cells: A promising approach to therapy.’
Poster 40 – Gordon Strathdee, ‘Utilising the origin of DNA methylation changes in cancer to enable the identification of cancer-specific SL genes as novel therapeutic targets’
Poster 41 – Beatriz Suárez, ‘Unraveling the "Histone Repair Code" in Ribosomal DNA: A Potential Therapeutic Avenue for Epigenetic Interventions’
Poster 42 - María Subijana Fernández de Larrinoa, ‘Class I Histone Deacetylases as potential regulators of the emergence of cancer-associated fibroblast phenotypes’
Poster 43 – Ellie Sweatman, ‘Loss of SETD1A drives PARP inhibitor resistance in a subset of homologous recombination-deficient cells’
Poster 44 – Tarryn Willmer, ‘Hypermethylation of the BRCA1 promoter is associated with early-onset breast cancer in Black African women’
Poster 45 - Büşra Yıldırım, ‘Characterization of the Transcriptional Regulation of ABCB1 Gene in Taxane Resistant Prostate Cancers by Genomic Locus Proteomics’
Poster 46 – Taras Zadvornyi, ‘miR-19a-3p and miR-23b-3p as biomarkers of prostate cancer progression’
Poster 47 – Giovanna Zinzalla, ‘New ways to target the SWI/SNF complexes in cancer and regenerative medicine’
This session will end at 13:30 CET so please make sure you give yourself enough time to browse each of the posters on display!
There will then be a 30-minute break before we move over to Zoom Webinar for our second day of scientific talks.
Dietary requirements (in-person events only)
Please indicate any special dietary requirements here. We will try to cater to all dietary requirements and we will write to you if there is any problem.
Sharing your details with others
Please click below if you agree we can share your name, email and postal address with participants and exhibitors, who may use them to contact you.
Please note: you have selected NOT to share your details with participants and exhibitors.
You can click above to change this.
We will use the email address in your EACR account to communicate with you. However, during the checkout process you will need to enter the name and contact details of the person paying for your registration, if this is different to your own details. Please make sure you have this information to hand.
Terms and Conditions
Please read our Membership and Events Terms and Conditions before completing your registration.
Photography and video
Please note that we will be taking photographs and video at the conference for publicity and marketing purposes. If you do not wish to take part please inform the photographer.
The EACR is grateful for the continued support of its Industry Partners: